NON-PROLIFERATIVE DIABETIC RETINOPATHY
Clinical trials for NON-PROLIFERATIVE DIABETIC RETINOPATHY explained in plain language.
Never miss a new study
Get alerted when new NON-PROLIFERATIVE DIABETIC RETINOPATHY trials appear
Sign up with your email to follow new studies for NON-PROLIFERATIVE DIABETIC RETINOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to clear fatty deposits in diabetic eyes
Disease control CompletedThis study tested whether adding a second drug (B55R2) to a standard treatment (B55R1) works better for people with non-proliferative diabetic retinopathy, an early stage of diabetic eye disease. The main goal was to see if the combination could reduce hard exudates—fatty deposit…
Matched conditions: NON-PROLIFERATIVE DIABETIC RETINOPATHY
Phase: PHASE4 • Sponsor: AJU Pharm Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 11:03 UTC
-
New eye drug shows promise for diabetic vision loss
Disease control CompletedThis study tested a drug called faricimab in 179 people with non-proliferative diabetic retinopathy, a common eye problem in diabetes. The goal was to see if monthly injections could improve blood flow in the retina over 48 weeks compared to just watching and waiting. The results…
Matched conditions: NON-PROLIFERATIVE DIABETIC RETINOPATHY
Phase: PHASE2 • Sponsor: Greater Houston Retina Research • Aim: Disease control
Last updated May 22, 2026 14:01 UTC